Abstract:Innate immunity is the first line to defend against pathogenic microorganisms, and Toll-like receptor (TLR)-mediated inflammatory responses are an essential component of innate immunity. However, the regulatory mechanisms of TLRs in innate immunity remain unperfected. We found that the expression of E3 ligase Ring finger protein 99 (RNF99) decreased significantly in peripheral blood monocytes from patients infected with Gram negative bacteria (G - ) and macrophages stimulated by TLRs ligands, indicating the role of RNF99. We also demonstrated for the first time, the protective role of RNF99 against LPS-induced septic shock and dextran sodium sulfate (DSS)-induced colitis using RNF99 knockout mice (RNF99 –/– ) and bone marrow-transplanted mice. In vitro experiments revealed that RNF99 deficiency significantly promoted TLR-mediated inflammatory cytokine expression and activated the NF-κB and MAPK pathways in macrophages. Mechanistically, in both macrophages and HEK293 cell line with TLR4 stably transfection, RNF99 interacted with and degraded TAK1-binding protein (TAB) 2, a regulatory protein of the kinase TAK1, via the lysine (K)48-linked ubiquitin-proteasomal pathway on lysine 611 of TAB2, which further regulated the TLR-mediated inflammatory response. Overall, these findings indicated the physiological significance of RNF99 in macrophages in regulating TLR-mediated inflammatory reactions. It provided new insight into TLRs signal transduction, and offered a novel approach for preventing bacterial infections, endotoxin shock, and other inflammatory ills.

RNF4 Negatively Regulates NF‐κB Signaling by Down‐regulating TAB2

RNF4 negatively regulates NF-κB signaling by down-regulating TAB2

RBCK1 Negatively Regulates Tumor Necrosis Factor- and Interleukin-1-triggered NF-κB Activation by Targeting TAB2/3 for Degradation

Trim30 Alpha Negatively Regulates Tlr-Mediated Nf-Kappa B Activation By Targeting Tab2 And Tab3 For Degradation

TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation

OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3

TRIM 30 a negatively regulates TLR-mediated NF-j B activation by targeting TAB 2 and TAB 3 for degradation

E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

Ubiquitin-associated Domain-containing Ubiquitin Regulatory X (UBX) Protein UBXN1 is a Negative Regulator of Nuclear Factor Κb (Nf-Κb) Signaling*

The E3 Ligase RNF34 is a Novel Negative Regulator of the NOD1 Pathway

RNF144B inhibits LPS-induced inflammatory responses via binding TBK1

NUMBL interacts with TAB2 and inhibits TNFalpha and IL-1beta-induced NF-kappaB activation

WDR34 is a Novel TAK1-associated Suppressor of the IL-1R/TLR3/TLR4-induced NF-κB Activation Pathway

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

LRRC14 Attenuates Toll-like Receptor-Mediated NF-κB Signaling Through Disruption of IKK Complex.

Reversible Ubiquitination Shapes NLRC5 Function and Modulates NF-κB Activation Switch

NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK

RNF149 negatively regulates LPS/TLR4 signal transduction by ubiquitination-mediated CD63 degradation

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

TAB2 Scaffolds TAK1 and NLK in Repressing Canonical Wnt Signaling